Ratchaphruek Hospital PCL (BKK:RPH)

Ratchaphruek Hospital PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,148	1,125	1,161	1,326	1,413	799.33
Revenue Growth (YoY)	-0.01%	-3.05%	-12.49%	-6.12%	76.72%	-2.11%
Cost of Revenue	758.93	751.44	750.58	827.01	746.98	566.64
Gross Profit	388.86	373.73	410.01	499.17	665.58	232.69
Selling, General & Admin	184.51	181.22	191.46	149.5	167.72	121.58
Operating Expenses	185.64	181.22	191.46	149.5	167.72	121.58
Operating Income	203.21	192.51	218.55	349.67	497.86	111.11
Interest Expense	-0.56	-0.57	-2.11	-5.55	-6.69	-7.83
Interest & Investment Income	6.58	6.58	2.78	0.81	0.35	0.35
Other Non Operating Income (Expenses)	17.85	17.85	14.16	13.26	11.54	12.86
EBT Excluding Unusual Items	227.08	216.37	233.38	358.19	503.07	116.49
Pretax Income	227.08	216.37	233.38	358.19	503.07	116.49
Income Tax Expense	48.22	43.84	48.92	71.73	100.07	22.64
Net Income	178.86	172.53	184.45	286.47	402.99	93.84
Net Income to Common	178.86	172.53	184.45	286.47	402.99	93.84
Net Income Growth	1.51%	-6.46%	-35.61%	-28.92%	329.43%	-2.67%
Shares Outstanding (Basic)	541	546	546	546	546	546
Shares Outstanding (Diluted)	541	546	546	546	546	546
Shares Change (YoY)	-0.91%	-0.01%	-	-	-	-
EPS (Basic)	0.33	0.32	0.34	0.52	0.74	0.17
EPS (Diluted)	0.33	0.32	0.34	0.52	0.74	0.17
EPS Growth	2.44%	-6.46%	-35.61%	-28.92%	329.43%	-2.67%
Free Cash Flow	227.59	230.62	342.38	420.32	271.25	131.88
Free Cash Flow Per Share	0.42	0.42	0.63	0.77	0.50	0.24
Dividend Per Share	0.280	0.290	0.300	0.350	0.300	0.130
Dividend Growth	-6.67%	-3.33%	-14.29%	16.67%	130.77%	-7.14%
Gross Margin	33.88%	33.22%	35.33%	37.64%	47.12%	29.11%
Operating Margin	17.71%	17.11%	18.83%	26.37%	35.24%	13.90%
Profit Margin	15.58%	15.33%	15.89%	21.60%	28.53%	11.74%
Free Cash Flow Margin	19.83%	20.50%	29.50%	31.69%	19.20%	16.50%
EBITDA	277.62	266.91	303.46	440.29	584.49	197.85
EBITDA Margin	24.19%	23.72%	26.15%	33.20%	41.38%	24.75%
D&A For EBITDA	74.4	74.4	84.91	90.62	86.62	86.74
EBIT	203.21	192.51	218.55	349.67	497.86	111.11
EBIT Margin	17.71%	17.11%	18.83%	26.37%	35.24%	13.90%
Effective Tax Rate	21.24%	20.26%	20.96%	20.02%	19.89%	19.44%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.